SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?


To: Peter Goss who wrote (3161)3/29/1998 1:17:00 AM
From: Linda Kaplan  Respond to of 7041
 
Do you think Zonagen can have income from Mexico in 1998? I agree that the company is overvalued, that they may never be approved and that it would be years till they get approval, even if they file now. Yes, they missed their chance to get expedited consideration by the FDA. I don't know why some think they won't file, but even if they do it will be years before they get approval and can market the drug, and by then the market will be saturated.

Linda